Business Wire · SVRA · October 12, 2026
Savara to Present New Analysis from the IMPALA Clinical Trial and Deliver Encore Presentation of Long-Term Data on Molgramostim in Autoimmune Pulmonary Alveolar Proteinosis (aPAP) at CHEST 2026

Get the app for more
Explore stock news, insights and company research.
Get the app → Source: Business Wire ↗